8-K
Current Report
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-043184
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea179301-8k_cadrenal.htm…